Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Lines Up $1 Billion For China R&D

Nov 03 2009

• By The Pink Sheet Daily

Related Content

Novartis’ Paul Herrling And En Li On R&amp;D Strategy In China, India And The Pacific Rim: An Interview With PharmAsia News (Part 2 of 2)

May 08 2008

Novartis’ Paul Herrling And En Li On R&amp;D Strategy In China, India And The Pacific Rim: An Interview With PharmAsia News (Part 1 of 2)

May 05 2008

China's Universities and Pharma: A Change In Power Balance?

Oct 16 2009

Novartis Signs MOU To Invest $100 Million In R&D, Exchanges With Korean Scientists By 2013

Oct 13 2009

Novartis To Step Up Investment In China

Jun 16 2009

Novartis Shanghai R&amp;D Center To Focus On Diseases Prevalent In China

Nov 06 2006

Additional Topics

China Asia Pacific BioPharmaceutical

More from China

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window